CSPC Pharmaceutical Group Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| 600276 | Jiangsu Hengrui Medicine | Buy |
15
|
¥44.75 | ¥56.49 | 20.67% | 0 | ¥284.55B |
| BGNE | BeiGene | Buy |
6
|
$172.85 | $285.19 | 55.63% | 2 | $18.08B |
| 1801 | Innovent Biologics | Buy |
6
|
HK$40.05 | HK$50.72 | 27.34% | 6 | HK$65.98B |
| 600196 | Shanghai Fosun Pharmaceutical ... | Outperform |
16
|
¥23.78 | ¥33.57 | 9.76% | 1 | ¥58.25B |
| 600062 | China Resources Double-Crane P... | Buy |
16
|
¥22.64 | ¥26.00 | 13.69% | 0 | ¥23.79B |
| 4105 | TTY Biopharm Company | Hold |
18
|
NT$77.50 | NT$86.00 | 11.61% | 0 | NT$19.22B |
| PSTV | Plus Therapeutics | Buy |
11
|
$2.24 | $11.00 | 569.64% | 2 | $9.92M |